PriceTargets.com logo

ALS - CPBLF Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $14.38
  • Forecasted Upside: 99.41%
  • Number of Analysts: 1
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 1 Buy Ratings
  • 0 Strong Buy Ratings
$7.21 As of 03/24/2023 01:00 AM ET
+0 (0.00%)

This chart shows the closing price for CPBLF by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New ALS Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for CPBLF and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for CPBLF

Analyst Price Target is $14.38
▲ +99.41% Upside Potential
This price target is based on 1 analysts offering 12 month price targets for ALS in the last 3 months. The average price target is $14.38, with a high forecast of $14.38 and a low forecast of $14.38. The average price target represents a 99.41% upside from the last price of $7.21.

This chart shows the closing price for CPBLF for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 1 polled investment analysts is to buy stock in ALS. This rating has held steady since March 2022, when it changed from a Hold consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
10/2/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
12/31/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
3/31/2022
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
6/29/2022
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
9/27/2022
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
12/26/2022
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
2/24/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
3/26/2023

Latest Recommendations

  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
5/26/2022ABN AmroUpgradeBuy$14.38
3/9/2021JPMorgan Chase & Co.UpgradeUnderweight ➝ Neutral
2/7/2021The Goldman Sachs GroupUpgradeNeutral ➝ Buy
(Data available from 3/26/2018 forward)

News Sentiment Rating

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
8/28/2022
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
9/27/2022
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
10/27/2022
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
11/26/2022
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
12/26/2022
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
1/25/2023
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
2/24/2023
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
3/26/2023

Current Sentiment

  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

  • No positive mentions tracked during this time.

Very Positive

  • No very positive mentions tracked during this time.
ALS logo
ALS Ltd. engages in the provision of technical services in the areas of testing, measurement and inspection, and supporting. It operates through the following segments: Life Sciences, Industrial, and Commodities. The Life Sciences segment provides analytical testing data to assist consulting and engineering firms, industry, and governments around the world in making decisions about environmental, food and pharmaceutical, electronics, and animal health testing matters. The Industrial segment focuses in asset care and tribology testing services to the energy, resources and infrastructure sectors. The Commodities segment involves in assaying and analytical testing services and metallurgical services for mining and mineral exploration companies and gives specialist services to the coal industry such as coal sampling, analysis and certification, formation evaluation services, and related analytical testing. The company was founded in 1863 and is headquartered in Brisbane, Australia.
Read More

Today's Range

Now: $7.21
Low: $7.21
High: $7.21

50 Day Range

MA: $7.91
Low: $6.72
High: $8.81

52 Week Range

Now: $7.21
Low: $7.21
High: $8.81

Volume

N/A

Average Volume

5,850 shs

Market Capitalization

N/A

P/E Ratio

24.95

Dividend Yield

7.18%

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of ALS?

The following Wall Street analysts have issued stock ratings on ALS in the last year: ABN Amro.
View the latest analyst ratings for CPBLF.

What is the current price target for ALS?

1 Wall Street analysts have set twelve-month price targets for ALS in the last year. Their average twelve-month price target is $14.38, suggesting a possible upside of 99.4%. ABN Amro has the highest price target set, predicting CPBLF will reach $14.38 in the next twelve months. ABN Amro has the lowest price target set, forecasting a price of $14.38 for ALS in the next year.
View the latest price targets for CPBLF.

What is the current consensus analyst rating for ALS?

ALS currently has 1 buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe CPBLF will outperform the market and that investors should add to their positions of ALS.
View the latest ratings for CPBLF.

What other companies compete with ALS?

Other companies that are similar to ALS include AllyMe Group, American Cannabis, Bureau Veritas, Intertek Group and Medicine Man Technologies. Learn More about companies similar to ALS.

How do I contact ALS's investor relations team?

ALS's physical mailing address is 32 Shand Street, Brisbane, Queensland (QLD). The company's listed phone number is (173) 367-7900. The official website for ALS is www.alsglobal.com. Learn More about contacing ALS investor relations.